⌕
908 Devices · MASS · Nasdaq
Tenet 59 · Mixed
Compare
$9.19−5.65%At closeTenet 59 · Mixed
$9.19−0.55 (−5.65%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

908 Devices (MASS) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Defense WorldNov 13, 2026 · 04:21 ET
What 908 Devices (MASS) Said on Its Q3 Earnings Call

908 Devices (NASDAQ: MASS) reported record third-quarter revenue of $19 million, up 35% from a year earlier, and raised the low end of its 2026 revenue forecast as demand for its detection devices grew internationally. T…

● Seeking AlphaNov 10, 2026 · 23:31 ET
908 Devices: Solid Q3 Results

908 Devices delivered strong Q3 results with 35% year-over-year revenue growth, beating analyst estimates, and achieving a record 308 device placements. Management raised the low end of its 2026 revenue guidance range to…

● Seeking AlphaNov 10, 2026 · 12:21 ET
908 Devices Inc. (MASS) Q3 2026 Earnings Call Transcript

908 Devices Inc. (MASS) Q3 2026 Earnings Call Transcript…

● Zacks Investment ResearchNov 10, 2026 · 09:10 ET
908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.15 per share a year ago.…

● Business WireNov 10, 2026 · 07:00 ETCOMPANY'S OWN WORDS
908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, toda…

● Business WireNov 4, 2026 · 07:00 ETCOMPANY'S OWN WORDS
908 Devices to Participate in the Stifel 2026 Healthcare Conference

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today…

● Seeking AlphaOct 30, 2026 · 05:55 ET
Riverwater Micro Opportunities Strategy Q3 2026 Portfolio Activity

We initiated a position in 908 Devices, a maker of portable chemical detection instruments used by hazmat teams, law enforcement, firefighters, and the military. We initiated a position in Bowhead Specialty Holdings, a s…

● Business WireOct 27, 2026 · 07:00 ETCOMPANY'S OWN WORDS
908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, annou…

● Defense WorldOct 13, 2026 · 03:29 ET
Critical Contrast: TTM Technologies (NASDAQ:TTMI) versus 908 Devices (NASDAQ:MASS)

TTM Technologies (NASDAQ: TTMI - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better investment? We will compare the two businesses based on the streng…

● Defense WorldOct 6, 2026 · 11:01 ET
908 Devices (NASDAQ:MASS) Hits New 52-Week High – Here’s What Happened

908 Devices Inc. (NASDAQ: MASS - Get Free Report)'s share price hit a new 52-week high during trading on Tuesday. The company traded as high as $13.30 and last traded at $12.8250, with a volume of 39458 shares trading ha…

● Defense WorldSep 21, 2026 · 06:29 ET
Financial Analysis: IPG Photonics (NASDAQ:IPGP) vs. 908 Devices (NASDAQ:MASS)

IPG Photonics (NASDAQ: IPGP - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of t…

● Defense WorldSep 20, 2026 · 05:54 ET
908 Devices (NASDAQ:MASS) SVP Sells $53,726.54 in Stock

908 Devices Inc. (NASDAQ: MASS - Get Free Report) SVP John Kenneweg sold 5,257 shares of the business's stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $10.22…

● Defense WorldSep 20, 2026 · 05:09 ET
Insider Selling: 908 Devices (NASDAQ:MASS) SVP Sells $216,343.89 in Stock

908 Devices Inc. (NASDAQ: MASS - Get Free Report) SVP John Kenneweg sold 21,399 shares of 908 Devices stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $10.11, for a total t…

● Defense WorldSep 12, 2026 · 03:49 ET
Comparing 908 Devices (NASDAQ:MASS) & Plexus (NASDAQ:PLXS)

Plexus (NASDAQ: PLXS - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their anal…

● Defense WorldSep 4, 2026 · 03:29 ET
BlackRock Inc. Takes $16.91 Million Position in 908 Devices Inc. $MASS

BlackRock Inc. acquired a new stake in shares of 908 Devices Inc. (NASDAQ: MASS) in a recent quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acq…

● Business WireSep 1, 2026 · 07:00 ETCOMPANY'S OWN WORDS
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, annou…

● Defense WorldAug 31, 2026 · 02:34 ET
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates

908 Devices (NASDAQ: MASS) outlined its strategy to expand in handheld chemical detection following second-quarter 2026 results that showed revenue growth, a narrower adjusted EBITDA loss and increasing recurring revenue…

● GuruFocusAug 21, 2026 · 20:25 ET
Is 908 Devices Inc (MASS) Overvalued After 3.3% Rally? GF Value Says Overvalued

On August 21, 2026, 908 Devices Inc (MASS) shares rose 3.3% to $10.68, marking a notable increase within its 52-week range of $5.03 to $10.70. The stock has sho…

● MarketBeatAug 17, 2026 · 22:02 ET
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection

908 Devices outlined its strategy to focus exclusively on handheld chemical and drug detection technologies for public safety and defense markets, following the divestiture of its life-sciences business line about 15 mon…

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

Quiet tape today.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.